Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies.

Abidi MZ, Sohail MR, Cummins N, Wilhelm M, Wengenack N, Brumble L, Shah H, Jane Hata D, McCullough A, Wendel A, Vikram HR, Kusne S, Litzow M, Letendre L, Lahr BD, Poeschla E, Walker RC.

Mycoses. 2014 Nov;57(11):687-98. doi: 10.1111/myc.12222.

2.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
3.

Combination echinocandin-polyene treatment of murine mucormycosis.

Ibrahim AS, Gebremariam T, Fu Y, Edwards JE Jr, Spellberg B.

Antimicrob Agents Chemother. 2008 Apr;52(4):1556-8. doi: 10.1128/AAC.01458-07.

4.

Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia.

Klimko NN, Khostelidi SN, Volkova AG, Popova MO, Bogomolova TS, Zuborovskaya LS, Kolbin AS, Medvedeva NV, Zuzgin IS, Simkin SM, Vasilyeva NV, Afanasiev BV.

Mycoses. 2014 Dec;57 Suppl 3:91-6. doi: 10.1111/myc.12247.

PMID:
25187314
5.

Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis.

Reed C, Bryant R, Ibrahim AS, Edwards J Jr, Filler SG, Goldberg R, Spellberg B.

Clin Infect Dis. 2008 Aug 1;47(3):364-71. doi: 10.1086/589857.

6.

[Combination antifungal therapy for invasive fungal disease in children with hematologic disease].

Qiu K, Deng L, Huang K, Guo H, Fang J, Xu H, Xue H, Li Y, Chen C, Zhou D.

Zhonghua Xue Ye Xue Za Zhi. 2015 Nov;36(11):912-7. doi: 10.3760/cma.j.issn.0253-2727.2015.11.005. Chinese.

PMID:
26632462
7.

Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009.

Hammond SP, Baden LR, Marty FM.

Antimicrob Agents Chemother. 2011 Nov;55(11):5018-21. doi: 10.1128/AAC.00536-11.

8.

Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis.

Kontoyiannis DP, Azie N, Franks B, Horn DL.

Mycoses. 2014 Apr;57(4):240-6. doi: 10.1111/myc.12149.

PMID:
24147728
10.

Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B.

Voitl P, Scheibenpflug C, Weber T, Janata O, Rokitansky AM.

Eur J Clin Microbiol Infect Dis. 2002 Aug;21(8):632-4. No abstract available.

PMID:
12226700
11.

Survival of a patient with trauma-induced mucormycosis using an aggressive surgical and medical approach.

Van Sickels N, Hoffman J, Stuke L, Kempe K.

J Trauma. 2011 Feb;70(2):507-9. doi: 10.1097/TA.0b013e31820784ff.

PMID:
21307754
12.

Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.

Blyth CC, Hale K, Palasanthiran P, O'Brien T, Bennett MH.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD006343. doi: 10.1002/14651858.CD006343.pub2. Review.

PMID:
20166083
13.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
14.

Case report of hepatic mucormycosis after liver transplantation: successful treatment with liposomal amphotericin B followed by posaconazole sequential therapy.

Abboud CS, Bergamasco MD, Baía CE, Lallée MP, Zan AS, Zamorano MM, Pereira OI, Mies S.

Transplant Proc. 2012 Oct;44(8):2501-2. doi: 10.1016/j.transproceed.2012.07.042.

PMID:
23026630
15.

Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins.

Ibrahim AS, Gebremariam T, Luo G, Fu Y, French SW, Edwards JE Jr, Spellberg B.

Antimicrob Agents Chemother. 2011 Apr;55(4):1768-70. doi: 10.1128/AAC.01577-10.

16.

Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.

Mezhir JJ, Mullane KM, Zarling J, Satoskar R, Pai RK, Roggin KK.

Surg Infect (Larchmt). 2009 Oct;10(5):447-51. doi: 10.1089/sur.2008.049. Review.

PMID:
19485785
17.

Combination antifungal therapy for invasive aspergillosis: a randomized trial.

Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, Heinz WJ, Jagannatha S, Koh LP, Kontoyiannis DP, Lee DG, Nucci M, Pappas PG, Slavin MA, Queiroz-Telles F, Selleslag D, Walsh TJ, Wingard JR, Maertens JA.

Ann Intern Med. 2015 Jan 20;162(2):81-9. doi: 10.7326/M13-2508. Erratum in: Ann Intern Med. 2015 Mar 17;162(6):463.

PMID:
25599346
18.

[Invasive zygomycosis in patients treated for haematological malignancies].

Verweij PE, van der Velden WJ, Donnelly JP, Blijlevens NM, Warris A.

Ned Tijdschr Geneeskd. 2007 Nov 24;151(47):2597-602. Dutch.

PMID:
18161258
19.

Eradication of invasive mucormycosis--effectiveness of the Echinocandin FK463.

Jacobs P, Wood L, Du Toit A, Esterhuizen K.

Hematology. 2003 Apr;8(2):119-23.

PMID:
12745662
20.

Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.

Blin N, Morineau N, Gaillard F, Morin O, Milpied N, Harousseau JL, Moreau P.

Leuk Lymphoma. 2004 Oct;45(10):2161-3.

PMID:
15370266
Items per page

Supplemental Content

Support Center